These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 24269617)

  • 1. Ascaridia galli infection influences the development of both humoral and cell-mediated immunity after Newcastle Disease vaccination in chickens.
    Pleidrup J; Dalgaard TS; Norup LR; Permin A; Schou TW; Skovgaard K; Vadekær DF; Jungersen G; Sørensen P; Juul-Madsen HR
    Vaccine; 2014 Jan; 32(3):383-92. PubMed ID: 24269617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune gene expression in the spleen of chickens experimentally infected with Ascaridia galli.
    Dalgaard TS; Skovgaard K; Norup LR; Pleidrup J; Permin A; Schou TW; Vadekær DF; Jungersen G; Juul-Madsen HR
    Vet Immunol Immunopathol; 2015 Mar; 164(1-2):79-86. PubMed ID: 25649508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses of poultry to Newcastle disease virus.
    Kapczynski DR; Afonso CL; Miller PJ
    Dev Comp Immunol; 2013 Nov; 41(3):447-53. PubMed ID: 23623955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of attenuated Newcastle disease (ND) vaccine with rHVT-ND vaccine at 1 day old is more protective against ND virus challenge than when combined with inactivated ND vaccine.
    Rauw F; Gardin Y; Palya V; van den Berg T; Lambrecht B
    Avian Pathol; 2014; 43(1):26-36. PubMed ID: 24283258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of parasite-specific immunoglobulin levels in two chicken lines during sustained infection with Ascaridia galli.
    Norup LR; Dalgaard TS; Pleidrup J; Permin A; Schou TW; Jungersen G; Fink DR; Juul-Madsen HR
    Vet Parasitol; 2013 Jan; 191(1-2):187-90. PubMed ID: 22981407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge.
    Zhao R; Sun J; Qi T; Zhao W; Han Z; Yang X; Liu S
    Vaccine; 2017 Apr; 35(18):2435-2442. PubMed ID: 28342665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of chicken T cell-mediated immune responses after Newcastle disease virus vaccination and challenge.
    Dalgaard TS; Norup LR; Pedersen AR; Handberg KJ; Jørgensen PH; Juul-Madsen HR
    Vaccine; 2010 Jun; 28(28):4506-14. PubMed ID: 20434546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposome.
    Onuigbo EB; Okore VC; Ofokansi KC; Okoye JO; Nworu CS; Esimone CO; Attama AA
    Avian Pathol; 2012; 41(4):355-60. PubMed ID: 22834549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis of Ascaridia galli infection in layer chicken.
    Schwarz A; Gauly M; Abel H; Daş G; Humburg J; Rohn K; Breves G; Rautenschlein S
    Dev Comp Immunol; 2011 Jul; 35(7):774-84. PubMed ID: 21382408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys.
    Hu H; Roth JP; Estevez CN; Zsak L; Liu B; Yu Q
    Vaccine; 2011 Nov; 29(47):8624-33. PubMed ID: 21925228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunisation of fancy chickens against Newcastle disease].
    Freund I; Dzapo V; Vielitz E; Redmann T; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):414-8. PubMed ID: 11721588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral-expressed recombinant granulocyte monocyte colony-stimulating factor (GM-CSF) enhances protective immunity induced by inactivated Newcastle Disease Virus (NDV) vaccine.
    Wang X; Wang X; Jia Y; Wang C; Han Q; Lu ZH; Yang Z
    Antiviral Res; 2017 Aug; 144():322-329. PubMed ID: 28698014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the immune responses to Newcastle disease vaccine in chickens.
    Zhai L; Li Y; Wang W; Wang Y; Hu S
    Vaccine; 2011 Jul; 29(31):5007-14. PubMed ID: 21569814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.